ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates reply

被引:0
|
作者
Voysey, Merryn [1 ]
Pollard, Andrew J. [1 ]
机构
[1] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England
来源
LANCET | 2021年 / 397卷 / 10291期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2248 / 2248
页数:1
相关论文
共 50 条
  • [31] Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
    Madhi, S. A.
    Baillie, V
    Cutland, C. L.
    Voysey, M.
    Koen, A. L.
    Fairlie, L.
    Padayachee, S. D.
    Dheda, K.
    Barnabas, S. L.
    Bhorat, Q. E.
    Briner, C.
    Kwatra, G.
    Ahmed, K.
    Aley, P.
    Bhikha, S.
    Bhiman, J. N.
    Bhorat, A' E.
    du Plessis, J.
    Esmail, A.
    Groenewald, M.
    Horne, E.
    Hwa, S-H
    Jose, A.
    Lambe, T.
    Laubscher, M.
    Malahleha, M.
    Masenya, M.
    Masilela, M.
    McKenzie, S.
    Molapo, K.
    Moultrie, A.
    Oelofse, S.
    Patel, F.
    Pillay, S.
    Rhead, S.
    Rodel, H.
    Rossouw, L.
    Taoushanis, C.
    Tegally, H.
    Thombrayil, A.
    van Eck, S.
    Wibmer, C. K.
    Durham, N. M.
    Kelly, E. J.
    Villafana, T. L.
    Gilbert, S.
    Pollard, A. J.
    de Oliveira, T.
    Moore, P. L.
    Sigal, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1885 - 1898
  • [32] Safety Warning for ChAdOx1 nCov-19 Vaccine in Patients with Sickle Cell Disease
    Alkindi, S.
    Elsadek, R. A.
    Pathare, A., V
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
  • [33] Herpes Zoster Following Vaccination with ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant)
    Job, Anupa Mary
    Sudhamani, Bindurani
    Mohan, Manju
    Mohanasundarama, S. N.
    INDIAN JOURNAL OF PUBLIC HEALTH, 2022, 66 (01) : 83 - 85
  • [34] Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia
    Greinacher, Andreas
    Selleng, Kathleen
    Palankar, Raghavendra
    Wesche, Jan
    Handtke, Stefan
    Wolff, Martina
    Aurich, Konstanze
    Lalk, Michael
    Methling, Karen
    Voelker, Uwe
    Hentschker, Christian
    Michalik, Stephan
    Steil, Leif
    Reder, Alexander
    Schoenborn, Linda
    Beer, Martin
    Franzke, Kati
    Buettner, Andreas
    Fehse, Boris
    Stavrou, Evi X.
    Rangaswamy, Chandini
    Mailer, Reiner K.
    Englert, Hanna
    Frye, Maike
    Thiele, Thomas
    Kochanek, Stefan
    Krutzke, Lea
    Siegerist, Florian
    Endlich, Nicole
    Warkentin, Theodore E.
    Renne, Thomas
    BLOOD, 2021, 138 (22) : 2256 - 2268
  • [35] Immunogenicity of Two Doses of ChAdOx1 nCoV-19 Vaccine in Lung Transplant Recipients
    Carlier, F. M.
    Closset, M.
    Catry, E.
    Dumonceaux, M.
    Douxfils, J.
    Frerotte, D.
    Evrard, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S134 - S135
  • [36] Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine
    Shin, Eunyong
    Bae, Seongman
    Jung, Jiwon
    Song, Woo-Jung
    Kwon, Hyouk-Soo
    Kim, Hee-Sung
    Kim, Sung-Han
    Kim, Tae-Bum
    Cho, You Sook
    Lee, Ji-Hyang
    ALLERGY, 2021, 76 (11) : 3520 - 3522
  • [37] Antibody response to ChAdOx1 nCoV-19 (Covishield®) vaccine in people on maintenance hemodialysis
    Bhadauria, Dharmendra Singh
    Tiwari, Prachi
    Goel, Amit
    Katiyar, Harshita
    Kaul, Anupma
    Mayank, Amita
    Aggarwal, Amita
    Verma, Alka
    Khetan, Dhiraj
    Yachha, Monika
    Behera, Manas Ranjan
    Yadav, Brijesh
    Agarwal, Kartik
    Prasad, Narayan
    SEMINARS IN DIALYSIS, 2023, 36 (06) : 477 - 482
  • [38] Healthcare professionals & adverse events of ChAdOx1 nCoV-19 coronavirus vaccine Response
    Kaur, Sukhpal
    Singh, Ajay
    Saini, Sushma
    Rohilla, Latika
    Kaur, Jasvir
    Chandi, Anadeep
    Kaur, Gurpreet
    Singh, Manjeet
    Kumar, Pramod
    Soni, Shiv Lal
    Kajal, Kamal
    Naik, Naveen B.
    Malhotra, Pankaj
    Verma, Sanjay
    Gupta, Madhu
    Devnani, Mahesh
    Das, Karobi
    Pandav, S. S.
    Puri, G. D.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (5-6) : 591 - 592
  • [39] IMMUNOGENICITY AND SAFETY OF CHADOX1 NCOV-19 VACCINE IN PRIMARY SJOGREN'S SYNDROME
    Libardi, Lira Machado K. L.
    Oliveira, Souza B.
    Barbosa, Beloni Lirio M.
    Neves, Burian A. P.
    Goncalves, Rodrigues DeAguiar L.
    Smith, Sobral Vieira G.
    Ribeiro, Moulaz, I
    Gomes, M. D. P.
    Tatiama, Miyamoto S.
    Vieira, Serrano E.
    Reis, Neto E.
    Teixeira-Carvalho, A.
    Valim, V.
    Monticielo, O. A.
    De, Souza V. A.
    Ferreira, G. A.
    Inoue, Sato E.
    Xavier, R.
    Salviato, Pillegi G.
    Mill, J. G.
    Assis, Martins-Filho O.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 83 - 83
  • [40] Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
    Lin, Ting-Yun
    Hung, Nai-Kuan
    Hung, Szu-Chun
    VACCINES, 2022, 10 (08)